We further used the Kaplan–Meier plotter tool to study the relationship between MYL9 expression and different clinicopathological factors in gastric and ovarian cancer, finding that MYL9 expression may affect the prognosis of gastric cancer patients by affecting lymph node metastasis. This evidence concerns the gene MYL9 and ovarian cancer.